@arjay
What they need to do is lose this conservative attitude
how many times have we the long termers suffered through conservatism
How long did we sit awaiting Tysabri results that had nothing whatsoever to do with us yet because our CEO in his wisdom linked us to tht trial and it failed we suffered by association
How many years did we sit on submitting an IND for 1102 with the FDA and now we are paying the price the FDA direction is stalled through the tox study
Why was the Monkey study carried out for the six months instead of the none months required to move the drug forwards by the FDA
Why was the early access programme for 1102 derailed because the drug manufacturer being different was unacceptable to the European regulators
Conservatism i have had a whole boat load of conservatism over the journey
And where has it ever got us nothing but road blocks
Like i said read and digest arjay the questions are in there up to this moment i have not seen anyone raise them
So what do they do arjay they get their A$$es over to the US and seek substantial funding to promote all their marvelous achievements within the pipe line
Enough said Arjay i could go on but i wont
- Forums
- ASX - By Stock
- PER
- Ann: ATL1102 Revised Plans accelerate reporting of unblinded data
Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-38
-
-
- There are more pages in this discussion • 314 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $71.22M |
Open | High | Low | Value | Volume |
7.9¢ | 7.9¢ | 7.9¢ | $7.9K | 100K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 69319 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 96314 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 69319 | 0.079 |
2 | 212658 | 0.078 |
1 | 200000 | 0.077 |
3 | 84700 | 0.076 |
4 | 206988 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 96314 | 2 |
0.082 | 97561 | 1 |
0.083 | 214000 | 1 |
0.084 | 161142 | 2 |
0.085 | 141000 | 2 |
Last trade - 10.32am 16/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online